Predictors of Low Clopidogrel Adherence Following Percutaneous Coronary Intervention

      Few data are available on factors associated with low adherence or early clopidogrel discontinuation after percutaneous coronary intervention (PCI). Patients (n = 284) were evaluated before hospital discharge after PCI to identify factors associated with low adherence to clopidogrel 30 days later. Adherence to daily medications before PCI was assessed using the 8-item Morisky Medication Adherence Scale (MMAS-8) and categorized as low (score <6), medium (score 6 to <8), or high (score 8). Low adherence to clopidogrel was defined as MMAS-8 score <6 (n = 21) or having discontinued clopidogrel (n = 11), which was ascertained during a 30-day interview after PCI. At 30 days after PCI, 11% of patients had low adherence to clopidogrel. Odds ratios (95% confidence intervals [CIs]) for low adherence to clopidogrel were 3.78 (1.09 to 13.1), 3.06 (1.36 to 6.87), 2.46 (0.97 to 6.27), and 3.36 (0.99 to 11.4) for patients who before PCI reported taking smaller doses of medication because of cost, had difficulty filling prescriptions, had difficulty reaching their primary physician, and were not comfortable asking their doctor for instructions, respectively. Odds ratios (95% CIs) for low clopidogrel adherence after PCI in patients with medium and low versus high adherence to daily medications before PCI were 6.13 (1.34 to 28.2) and 10.9 (2.46 to 48.7), respectively. The c-statistic associated with MMAS-8 scores before PCI for discriminating low clopidogrel adherence at 30 days after PCI was 0.733 (95% CI 0.650 to 0.852). In conclusion, adherence to daily medications before PCI may be a useful indicator for identifying patients who will have low clopidogrel adherence after PCI.
      To read this article in full you will need to make a payment

      References

        • King III, S.B.
        • Smith Jr, S.C.
        • Hirshfeld Jr, J.W.
        • Jacobs A.K.
        • Morrison D.A.
        • Williams D.O.
        • Feldman T.E.
        • Kern M.J.
        • O'Neill W.W.
        • Schaff H.V.
        • Whitlow P.L.
        • Adams C.D.
        • Anderson J.L.
        • Buller C.E.
        • Creager M.A.
        • Ettinger S.M.
        • Halperin J.L.
        • Hunt S.A.
        • Krumholz H.M.
        • Kushner F.G.
        • Lytle B.W.
        • Nishimura R.
        • Page R.L.
        • Riegel B.
        • Tarkington L.G.
        • Yancy C.W.
        2007 Focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association task force on practice guidelines: 2007 writing group to review new evidence and update the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention, writing on behalf of the 2005 writing committee.
        Circulation. 2008; 117: 261-295
        • Horne R.
        • Weinman J.
        Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness.
        J Psychosom Res. 1999; 47: 555-567
        • Horne R.
        • Weinman J.
        • Hankins M.
        The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication.
        Psychol Health. 1999; 14: 1-24
        • Byrne M.
        • Walsh J.
        • Murphy A.W.
        Secondary prevention of coronary heart disease: patient beliefs and health-related behaviour.
        J Psychosom Res. 2005; 58: 403-415
        • Sud A.
        • Kline-Rogers E.M.
        • Eagle K.A.
        • Fang J.
        • Armstrong D.F.
        • Rangarajan K.
        • Otten R.F.
        • Stafkey-Mailey D.R.
        • Taylor S.D.
        • Erickson S.R.
        Adherence to medications by patients after acute coronary syndromes.
        Ann Pharmacother. 2005; 39: 1792-1797
        • Morisky D.E.
        • Ang A.
        • Krousel-Wood M.
        • Ward H.J.
        Predictive validity of a medication adherence measure in an outpatient setting.
        J Clin Hypertens (Greenwich). 2008; 10: 348-354
        • Krousel-Wood M.
        • Islam T.
        • Webber L.S.
        • Re R.N.
        • Morisky D.E.
        • Muntner P.
        New medication adherence scale versus pharmacy fill rates in seniors with hypertension.
        Am J Manag Care. 2009; 15: 59-66
        • Krousel-Wood M.A.
        • Muntner P.
        • Islam T.
        • Morisky D.E.
        • Webber L.S.
        Barriers to and determinants of medication adherence in hypertension management: perspective of the cohort study of medication adherence among older adults.
        Med Clin North Am. 2009; 93: 753-769
        • Mehta S.R.
        • Yusuf S.
        • Peters R.J.
        • Bertrand M.E.
        • Lewis B.S.
        • Natarajan M.K.
        • Malmberg K.
        • Rupprecht H.
        • Zhao F.
        • Chrolavicius S.
        • Copland I.
        • Fox K.A.
        Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study.
        Lancet. 2001; 358: 527-533
        • Spertus J.A.
        • Kettelkamp R.
        • Vance C.
        • Decker C.
        • Jones P.G.
        • Rumsfeld J.S.
        • Messenger J.C.
        • Khanal S.
        • Peterson E.D.
        • Bach R.G.
        • Krumholz H.M.
        • Cohen D.J.
        Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry.
        Circulation. 2006; 113: 2803-2809
        • Jeremias A.
        • Sylvia B.
        • Bridges J.
        • Kirtane A.J.
        • Bigelow B.
        • Pinto D.S.
        • Ho K.K.
        • Cohen D.J.
        • Garcia L.A.
        • Cutlip D.E.
        • Carrozza Jr, J.P.
        Stent thrombosis after successful sirolimus-eluting stent implantation.
        Circulation. 2004; 109: 1930-1932
        • Iakovou I.
        • Schmidt T.
        • Bonizzoni E.
        • Ge L.
        • Sangiorgi G.M.
        • Stankovic G.
        • Airoldi F.
        • Chieffo A.
        • Montorfano M.
        • Carlino M.
        • Michev I.
        • Corvaja N.
        • Briguori C.
        • Gerckens U.
        • Grube E.
        • Colombo A.
        Incidence, predictors, and outcome of thrombosis after successful implantation of drug-eluting stents.
        JAMA. 2005; 293: 2126-2130
        • Osterberg L.
        • Blaschke T.
        Adherence to medication.
        N Engl J Med. 2005; 353: 487-497
        • Stephenson B.J.
        • Rowe B.H.
        • Haynes R.B.
        • Macharia W.M.
        • Leon G.
        The rational clinical examination.
        JAMA. 1993; 269: 2779-2781
        • Mushlin A.I.
        • Appel F.A.
        Diagnosing potential noncompliance.
        Arch Intern Med. 1977; 137: 318-321
        • Kim M.T.
        • Hill M.N.
        • Bone L.R.
        • Levine D.M.
        Development and testing of the Hill-Bone Compliance to High Blood Pressure Therapy Scale.
        Prog Cardiovasc Nurs. 2000; 15: 90-96
        • McHorney C.A.
        The Adherence Estimator: a brief, proximal screener for patient propensity to adhere to prescription medications for chronic disease.
        Curr Med Res Opin. 2009; 25: 215-238